Fernanda Paiva

Ms. Fernanda Paiva


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2019 in Nature Catalysis
Verified
Journal Article
Closed access
PDF file
RLRory Little
Rory Little
FPFernanda Paiva
Fernanda Paiva
RJRobert Jenkins
Robert Jenkins
HHHui Hong
Hui Hong
Yuhui SunYuhui Sun
Yuhui Sun
PLPeter F. Leadlay
Peter F. Leadlay

5 December 2017 in Molecules
Verified
Journal Article
Open access
PDF file
FPFernanda Paiva
Fernanda Paiva
GFGlaucio Monteiro Ferreira
Glaucio Monteiro Ferreira
GTGustavo Trossini
Gustavo Trossini
Ernani PintoErnani Pinto
Ernani Pinto
Cyanobacteria are able to produce a wide range of secondary metabolites, including toxins and protease inhibitors, with diverse biological activities. Microginins are small linear peptides biosynthesized by cyanobacteria species that act against proteases. The aim of this study was to isolate and identify microginins produced by the LTPNA08 strain of Microcystis aeruginosa, as well as to verify their potential to inhibit angiotensin-converting enzyme (ACE; EC. 3.4.15.1) using in vitro and in silico methods. The fractionation of cyanobacterial extracts was performed by liquid chromatography and the presence of microginins was monitored by both LC-MS and an ACE inhibition assay. Enzyme inhibition was assayed by ACE with hippuryl-histidyl-leucine as the substrate; monitoring of hippuric acid was performed by HPLC-DAD. Isolated microginins were confirmed by mass spectrometry and were used to carry out the enzymatic assay. Molecular docking was used to evaluate microginin 770 (MG 770) and captopril (positive control), in order to predict similar binding interactions and determine the inhibitory action of ACE. The enzyme assay confirmed that MG 770 can efficiently inhibit ACE, with an IC50 equivalent to other microginins. MG 770 presented with comparable interactions with ACE, having features in common with commercial inhibitors such as captopril and enalaprilate, which are frequently used in the treatment of hypertension in humans.

19 November 2020 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
FPFernanda Paiva
Fernanda Paiva
KCKaren Chan
Karen Chan
MSMarkiyan Samborskyy
Markiyan Samborskyy
ASAriel M. Silber
Ariel M. Silber
PLPeter F. Leadlay
Peter F. Leadlay
MDMarcio V. B. Dias
Marcio V. B. Dias

24 June 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
LALaura A. Rivas Arenas
Laura A. Rivas Arenas
FPFernanda Paiva
Fernanda Paiva
NRNicolas de O. Rossini
Nicolas de O. Rossini
YLYanYan Li
YanYan Li
JSJonathan Spencer
Jonathan Spencer
MDMarcio V.B. Dias
Marcio V.B. Dias